Exposure to potential drug interactions in primary health care

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Exposure to potential drug interactions in primary health care. / Bjerrum, Lars; Andersen, Morten; Petersen, Gert; Kragstrup, Jakob.

In: Scandinavian Journal of Primary Health Care, Vol. 21, No. 3, 09.2003, p. 153-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bjerrum, L, Andersen, M, Petersen, G & Kragstrup, J 2003, 'Exposure to potential drug interactions in primary health care', Scandinavian Journal of Primary Health Care, vol. 21, no. 3, pp. 153-8. https://doi.org/10.1080/02813430310001806

APA

Bjerrum, L., Andersen, M., Petersen, G., & Kragstrup, J. (2003). Exposure to potential drug interactions in primary health care. Scandinavian Journal of Primary Health Care, 21(3), 153-8. https://doi.org/10.1080/02813430310001806

Vancouver

Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scandinavian Journal of Primary Health Care. 2003 Sep;21(3):153-8. https://doi.org/10.1080/02813430310001806

Author

Bjerrum, Lars ; Andersen, Morten ; Petersen, Gert ; Kragstrup, Jakob. / Exposure to potential drug interactions in primary health care. In: Scandinavian Journal of Primary Health Care. 2003 ; Vol. 21, No. 3. pp. 153-8.

Bibtex

@article{68bb36d832944ef48e3a74311360b610,
title = "Exposure to potential drug interactions in primary health care",
abstract = "OBJECTIVE: To analyse the prevalence of potential drug interactions, and to identify patients particularly prone to drug interaction.DESIGN: Database study (Odense University Pharmacoepidemiologic Database).SETTING: Individuals exposed to polypharmacy in 1999 were examined for potential drug interactions.SUBJECTS: Inhabitants of the County of Funen (n = 471 732).MAIN OUTCOME MEASURES: Prevalence of potential drug interactions.RESULTS: One-third of the population were exposed to polypharmacy and among these 15% were exposed to drugs carrying a risk of harmful interaction. Among the elderly with polypharmacy, 25% aged 60-79 years and 36% over 80 years received drugs carrying the risk of interaction. Among individuals exposed to potential drug interaction, 62% were exposed only to one drug interaction and 38% to two or more different drug interactions. The drugs accounting for the highest number of potential interactions were diuretics, NSAIDs, ACE-inhibitors, digoxin, oral antidiabetics, calcium channel blockers, anticoagulants and beta-blockers. When focusing only on major drug interactions, potassium-sparing diuretics and oral anticoagulants were the most frequently involved drugs.CONCLUSION: Elderly patients exposed to polypharmacy should be kept under intensified monitoring as they are at increased risk of clinically significant drug interactions.",
keywords = "Adult, Aged, Aged, 80 and over, Denmark/epidemiology, Drug Interactions, Family Practice/statistics & numerical data, Female, Humans, Male, Middle Aged, Polypharmacy, Risk Factors",
author = "Lars Bjerrum and Morten Andersen and Gert Petersen and Jakob Kragstrup",
year = "2003",
month = sep,
doi = "10.1080/02813430310001806",
language = "English",
volume = "21",
pages = "153--8",
journal = "Scandinavian Journal of Primary Health Care",
issn = "0281-3432",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Exposure to potential drug interactions in primary health care

AU - Bjerrum, Lars

AU - Andersen, Morten

AU - Petersen, Gert

AU - Kragstrup, Jakob

PY - 2003/9

Y1 - 2003/9

N2 - OBJECTIVE: To analyse the prevalence of potential drug interactions, and to identify patients particularly prone to drug interaction.DESIGN: Database study (Odense University Pharmacoepidemiologic Database).SETTING: Individuals exposed to polypharmacy in 1999 were examined for potential drug interactions.SUBJECTS: Inhabitants of the County of Funen (n = 471 732).MAIN OUTCOME MEASURES: Prevalence of potential drug interactions.RESULTS: One-third of the population were exposed to polypharmacy and among these 15% were exposed to drugs carrying a risk of harmful interaction. Among the elderly with polypharmacy, 25% aged 60-79 years and 36% over 80 years received drugs carrying the risk of interaction. Among individuals exposed to potential drug interaction, 62% were exposed only to one drug interaction and 38% to two or more different drug interactions. The drugs accounting for the highest number of potential interactions were diuretics, NSAIDs, ACE-inhibitors, digoxin, oral antidiabetics, calcium channel blockers, anticoagulants and beta-blockers. When focusing only on major drug interactions, potassium-sparing diuretics and oral anticoagulants were the most frequently involved drugs.CONCLUSION: Elderly patients exposed to polypharmacy should be kept under intensified monitoring as they are at increased risk of clinically significant drug interactions.

AB - OBJECTIVE: To analyse the prevalence of potential drug interactions, and to identify patients particularly prone to drug interaction.DESIGN: Database study (Odense University Pharmacoepidemiologic Database).SETTING: Individuals exposed to polypharmacy in 1999 were examined for potential drug interactions.SUBJECTS: Inhabitants of the County of Funen (n = 471 732).MAIN OUTCOME MEASURES: Prevalence of potential drug interactions.RESULTS: One-third of the population were exposed to polypharmacy and among these 15% were exposed to drugs carrying a risk of harmful interaction. Among the elderly with polypharmacy, 25% aged 60-79 years and 36% over 80 years received drugs carrying the risk of interaction. Among individuals exposed to potential drug interaction, 62% were exposed only to one drug interaction and 38% to two or more different drug interactions. The drugs accounting for the highest number of potential interactions were diuretics, NSAIDs, ACE-inhibitors, digoxin, oral antidiabetics, calcium channel blockers, anticoagulants and beta-blockers. When focusing only on major drug interactions, potassium-sparing diuretics and oral anticoagulants were the most frequently involved drugs.CONCLUSION: Elderly patients exposed to polypharmacy should be kept under intensified monitoring as they are at increased risk of clinically significant drug interactions.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Denmark/epidemiology

KW - Drug Interactions

KW - Family Practice/statistics & numerical data

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Polypharmacy

KW - Risk Factors

U2 - 10.1080/02813430310001806

DO - 10.1080/02813430310001806

M3 - Journal article

C2 - 14531506

VL - 21

SP - 153

EP - 158

JO - Scandinavian Journal of Primary Health Care

JF - Scandinavian Journal of Primary Health Care

SN - 0281-3432

IS - 3

ER -

ID: 324177755